Trial Profile
A Randomized, Parallel, Open-Label Study to Compare Once Per Day Sevelamer Carbonate Powder Dosing With Three Times Per Day Sevelamer Hydrochloride Tablet Dosing in Chronic Kidney Disease Patients on Hemodialysis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Genzyme Corporation
- 20 May 2014 New trial record